Gujarat Terce Laboratories share news and announcements
BSE: 524314Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹36.91.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹27 Cr3,856th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 7 Aug 2026
- 12.7
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹0.45 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 10.5
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 30 May 2026
- 2.7
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 7 Aug 2026
- 25.8%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹0.45 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 31.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 7 Aug 2026
- 25.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 30 May 2026
- 0.13
- Volume, BSEVolume. Shares traded on the last trading day.
- 3,356
Gujarat Terce Laboratories share news and announcements
523 announcements, routine notices left out, newest first. Page 2 of 11.
May 2025
26 May · Board meeting
19 May · Board meeting
Meeting on 26 May 2025: audited results
Apr 2025
11 Apr · Non-Applicability Of Corporate Governance Under Regulation 27(2) Of SEBI (LODR) Regulations, 2015 For The Quarter And Financial Year Ended 31St March, 2025.
Mar 2025
Feb 2025
Jan 2025
27 Jan · Board meeting
Meeting on 4 Feb 2025: quarterly results3 Jan · Non-Applicability Of Corporate Governance Under Regulation 27(2) Of SEBI (LODR) Regulations, 2015 For The Quarter Ended 31St December, 2024.
Nov 2024
Oct 2024
18 Oct · Board meeting
Meeting on 28 Oct 2024: annual general meeting and quarterly results
Sep 2024
Aug 2024
16 Aug · Announcement Under Regulation 30 (LODR) - Non-Applicability Of Corporate Governance Report For The Quarter Ended 30.09.2024
9 Aug · Board meeting
2 Aug · Board meeting
Meeting on 9 Aug 2024: annual general meeting and quarterly results
Jul 2024
1 Jul · Announcement under Regulation 30 (LODR)-Allotment
Jun 2024
May 2024
30 May · Intimation About Non-Applicability Of Disclosure Of Related Party Transactions Under Regulation 23 Of The SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.
29 May · Board meeting
29 May · Board meeting
21 May · Board meeting
Meeting on 29 May 2024: audited results
Apr 2024
19 Apr · Revised Submission Of Certificate Under Regulation 40(9) Of SEBI (LODR) Regulations, 2015 For The Year Ended On March 31, 2024
19 Apr · Submission Of Certificate Under Requlation 40(9) Of SEBI (LODR) Regulations, 2015 For The Year Ended On March 31, 2024
9 Apr · Compliance Certificate Pursuant To Regulation 7 (3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015,
Mar 2024
22 Mar · Board meeting
Meeting on 29 Mar 2024: preferential issue of shares